• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙开展的一项观察性研究:评估女性开始使用抗吸收药物(联合或不联合钙和维生素 D 补充剂)治疗时的治疗依从性。

Observational study of treatment compliance in women initiating antiresorptive therapy with or without calcium and vitamin D supplements in Spain.

机构信息

Servicio de Medicina Interna, Hospital Nuestra Señora del Mar, Barcelona, Spain.

出版信息

Menopause. 2012 Jan;19(1):89-95. doi: 10.1097/gme.0b013e318223bd6b.

DOI:10.1097/gme.0b013e318223bd6b
PMID:21934533
Abstract

OBJECTIVE

The aims of this study were to evaluate the compliance with antiresorptive therapy (ART) and supplements in Spain and to analyze the validity of the different treatment compliance assessment methods.

METHODS

A cross-sectional study with retrospective data collection was carried out in women starting ART, evaluating indirect objective compliance, self-reported compliance, and the Morisky-Green questionnaire.

RESULTS

A total of 480 women with a mean (SD) age of 65.8 (9.2) years were studied. Of these women, 62.9% received calcium and/or vitamin D supplements in addition to ART. According to the objective compliance method, 76.9% of the women were compliers (≥80%) with bisphosphonates; 69.4%, with selective estrogen receptor modulators; and 61.8%, with supplements (P < 0.01). Using the self-reported compliance, we identified 91% compliers with antiresorptive drugs and 75% with supplements. Using the Morisky-Green test, we classified 60.8% of the women as compliers with antiresorptive drugs and 48.4% with supplements. Combining the objective and self-reported compliance, 29.5% of the women did not adequately comply with ART and 56% with the drug supplements.

CONCLUSIONS

With all three compliance measures, supplements were the treatment yielding the lowest percentage of compliers. Bisphosphonates constituted the treatment offering the best objective compliance: 38.2% of the women with drug supplements and between 23.1% and 30.6% of the women with ART failed to exceed the theoretical value of 80% regarded as representing good compliance.

摘要

目的

本研究旨在评估西班牙抗吸收治疗(ART)和补充剂的依从性,并分析不同治疗依从性评估方法的有效性。

方法

本研究为回顾性横断面研究,纳入开始 ART 的女性,评估间接客观依从性、自我报告依从性和 Morisky-Green 问卷。

结果

共纳入 480 名年龄(均数±标准差)为 65.8±9.2 岁的女性。其中,62.9%的女性在接受 ART 的同时服用钙和/或维生素 D 补充剂。根据客观依从性方法,76.9%的女性对双膦酸盐的依从性≥80%;69.4%对选择性雌激素受体调节剂的依从性≥80%;61.8%对补充剂的依从性≥80%(P<0.01)。采用自我报告依从性,我们发现 91%的女性对抗吸收药物的依从性良好,75%的女性对补充剂的依从性良好。采用 Morisky-Green 测试,我们将 60.8%的女性归类为抗吸收药物的依从者,48.4%的女性归类为补充剂的依从者。将客观和自我报告的依从性相结合,29.5%的女性没有充分遵守 ART,56%的女性没有充分遵守药物补充剂。

结论

用所有三种依从性测量方法,补充剂的依从性最低。双膦酸盐是客观依从性最好的治疗方法:38.2%的女性在药物补充剂方面,23.1%至 30.6%的女性在 ART 方面没有超过 80%这一被认为是良好依从性的理论值。

相似文献

1
Observational study of treatment compliance in women initiating antiresorptive therapy with or without calcium and vitamin D supplements in Spain.西班牙开展的一项观察性研究:评估女性开始使用抗吸收药物(联合或不联合钙和维生素 D 补充剂)治疗时的治疗依从性。
Menopause. 2012 Jan;19(1):89-95. doi: 10.1097/gme.0b013e318223bd6b.
2
[Analysis of therapeutic compliance in women with osteoporosis].
Reumatol Clin. 2011 Sep-Oct;7(5):299-304. doi: 10.1016/j.reuma.2010.12.003. Epub 2011 May 4.
3
Self-reported compliance with osteoporosis medication-qualitative aspects and correlates.自我报告的骨质疏松症药物依从性——定性方面及相关因素
Maturitas. 2008 Jul-Aug;60(3-4):223-9. doi: 10.1016/j.maturitas.2008.07.009. Epub 2008 Sep 6.
4
Calcium and vitamin D intake by postmenopausal women with osteoporosis in France.法国骨质疏松症绝经后妇女的钙和维生素 D 摄入量。
Curr Med Res Opin. 2010 Jul;26(7):1667-74. doi: 10.1185/03007995.2010.483658.
5
[Initial treatment trends in patient with osteoporosis: use of antiresorptive agents and pharmacologic supplements (calcium and vitamin D) in clinical practice].
Reumatol Clin. 2012 Jan-Feb;8(1):3-9. doi: 10.1016/j.reuma.2011.07.006. Epub 2011 Nov 25.
6
[Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].[临床实践中的雷洛昔芬。非干预性研究CORAL(雷洛昔芬依从性研究)的结果]
Vnitr Lek. 2008 Mar;54(3):217-9, 221-4.
7
Ability to follow drug treatment with calcium and vitamin D in postmenopausal women with reduced bone mass.绝经后骨量减少妇女服用钙和维生素 D 药物的依从性。
Menopause. 2012 Sep;19(9):989-94. doi: 10.1097/gme.0b013e318247e86a.
8
Total calcium intake is associated with cortical bone mineral density in a cohort of postmenopausal women not taking estrogen.在一组未服用雌激素的绝经后女性中,总钙摄入量与皮质骨矿物质密度相关。
J Nutr Health Aging. 2003;7(5):296-9.
9
Physician and patient perceptions on the use of vitamin D and calcium in osteoporosis treatment: a European and Latin American perspective.医生与患者对维生素D和钙在骨质疏松症治疗中应用的看法:欧洲和拉丁美洲视角
Curr Med Res Opin. 2007 Jun;23(6):1227-37. doi: 10.1185/030079907X187964. Epub 2007 Apr 30.
10
Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.评估特立帕肽在接受抗吸收治疗时发生骨折或对先前抗吸收治疗不耐受的骨质疏松症患者中的依从性、接受度和耐受性:一项为期18个月的多中心、开放标签、前瞻性研究。
Clin Ther. 2007 Sep;29(9):2055-67. doi: 10.1016/j.clinthera.2007.09.024.

引用本文的文献

1
Evaluating adherence, tolerability and safety of oral calcium citrate in elderly osteopenic subjects: a real-life non-interventional, prospective, multicenter study.评价口服柠檬酸钙在老年骨质减少症患者中的依从性、耐受性和安全性:一项真实世界的、非干预性、前瞻性、多中心研究。
Aging Clin Exp Res. 2024 Feb 12;36(1):38. doi: 10.1007/s40520-024-02696-9.
2
Effect of Denosumab on Bone Density in Postmenopausal Osteoporosis: A Comparison with and without Calcium Supplementation in Patients on Standard Diets in Korea.地诺单抗对绝经后骨质疏松症骨密度的影响:韩国标准饮食患者补充钙剂与未补充钙剂的比较
J Clin Med. 2023 Nov 2;12(21):6904. doi: 10.3390/jcm12216904.
3
Fixation Using Alternative Implants for the Treatment of Hip Fractures: The feasibility of a multicenter 2 × 2 factorial randomized controlled trial evaluating surgical treatment and vitamin D supplementation in young femoral neck fracture patients.
使用替代植入物固定治疗髋部骨折:一项多中心2×2析因随机对照试验评估年轻股骨颈骨折患者手术治疗和维生素D补充的可行性。
OTA Int. 2020 May 21;3(2):e066. doi: 10.1097/OI9.0000000000000066. eCollection 2020 Jun.
4
The effects of single high-dose or daily low-dosage oral colecalciferol treatment on vitamin D levels and muscle strength in postmenopausal women.单次高剂量或每日低剂量口服骨化三醇治疗对绝经后女性维生素D水平和肌肉力量的影响。
BMC Endocr Disord. 2018 Jul 21;18(1):48. doi: 10.1186/s12902-018-0277-8.
5
A Missed Opportunity in Bone Health: Vitamin D and Calcium Use in Elderly Femoral Neck Fracture Patients Following Arthroplasty.骨骼健康领域的一个错失良机:人工关节置换术后老年股骨颈骨折患者维生素D和钙的使用情况
Geriatr Orthop Surg Rehabil. 2017 Dec;8(4):215-224. doi: 10.1177/2151458517735201. Epub 2017 Oct 25.
6
Effect of oral versus intramuscular Vitamin D replacement in apparently healthy adults with Vitamin D deficiency.口服与肌肉注射维生素D补充剂对明显健康的维生素D缺乏成年人的影响。
Indian J Endocrinol Metab. 2017 Jan-Feb;21(1):131-136. doi: 10.4103/2230-8210.196007.
7
Patterns of Non-adherence to Supplementation with Calcium and Vitamin D in Persistent Postmenopausal Women Are Similar at Start and 1 Year Later: A Qualitative Longitudinal Study.持续性绝经后女性钙和维生素D补充治疗的不依从模式在开始时和1年后相似:一项定性纵向研究
Front Pharmacol. 2016 Sep 30;7:339. doi: 10.3389/fphar.2016.00339. eCollection 2016.
8
Drug holidays: the most frequent type of noncompliance with calcium plus vitamin D supplementation in persistent patients with osteoporosis.药物假期:持续性骨质疏松患者中最常见的不坚持补充钙加维生素D的情况。
Patient Prefer Adherence. 2015 Dec 16;9:1771-9. doi: 10.2147/PPA.S88630. eCollection 2015.
9
A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods.一项IV期双臂随机交叉研究,比较在两个6个月期间每月一次服用维生素D3与每日服用固定剂量维生素D3和钙组合的依从性。
Osteoporos Int. 2015 Dec;26(12):2863-8. doi: 10.1007/s00198-015-3205-z. Epub 2015 Jun 23.
10
Topical delivery of vitamin d3: a randomized controlled pilot study.维生素D3的局部给药:一项随机对照试验研究
Int J Biomed Sci. 2014 Mar;10(1):21-4.